Peptide entry
Cagrilintide
Evidence / context
Evidence: Emerging. Use context is formulation-dependent.
Available vial formats
- Conservative 0.125-0.25 mg once weekly (5-10 units per weekly injection)
- Standard 0.5-1.0 mg once weekly (20-40 units per weekly injection)
- Aggressive 1.2-2.4 mg once weekly (48-96 units per weekly injection) only with slow titration and clear tolerance
- Cycle length 8-20+ weeks depending on response.
- Best timing Same day each week, often evening.
Titration schedule
- Weeks 1-4: 0.25 mg once weekly
- Weeks 5-8: 0.5 mg once weekly
- Weeks 9-12: 1.2 mg once weekly if tolerated
- Week 13+: 2.4 mg once weekly maximum if tolerated
- Escalate roughly every 4 weeks only if tolerated (research/trial convention, not a label schedule).
- Hold the current dose longer if nausea or appetite suppression is too strong.
- Often paired with an incretin; when stacking, titrate only one agent at a time.
Reconstitution
- Swab vial tops with alcohol
- Add 2.0 mL bacteriostatic water slowly
- Swirl gently - do not shake
- Refrigerate 2-8 C
Dosing, cycle & timing
- Conservative 0.125-0.25 mg once weekly (5-10 units per weekly injection)
- Standard 0.5-1.0 mg once weekly (20-40 units per weekly injection)
- Aggressive 1.2-2.4 mg once weekly (48-96 units per weekly injection) only with slow titration and clear tolerance
- Cycle length 8-20+ weeks depending on response.
- Best timing Same day each week, often evening.
Timing: Treat like a satiety-focused weekly tool. Move up slowly and hold longer if GI side effects persist. Keep meals smaller during early titration.
Support / expected effects
- Satiety and appetite-support context, usually as part of a broader fat-loss plan.
- May help reduce food noise when titrated slowly.
- Most useful when protein, hydration, and GI tolerance are actively managed.
Side effects / tolerability
- Nausea
- Early fullness
- Constipation
- Fatigue in some users
Notes
- Clinical note: use context is formulation-dependent.
- Future finished-product formulations may differ from vial formats.
- Keep appetite-agent stacks simple enough to interpret.
Practical tips
- Hold dose rather than escalating into persistent nausea.
- Protein intake matters more as appetite drops.
- Track bowel habits and hydration.
Storage
Refrigerate 2-8 C after mixing and follow the product-specific beyond-use window.
Related peptides
Related goal guides
Related categories
FAQ
What is Cagrilintide explored for?
Satiety and appetite-support context, usually as part of a broader fat-loss plan. May help reduce food noise when titrated slowly. Most useful when protein, hydration, and GI tolerance are actively managed.
How is Cagrilintide reconstituted?
1) Swab vial tops with alcohol 2) Add 2.0 mL bacteriostatic water slowly 3) Swirl gently - do not shake 4) Refrigerate 2-8 C
What is a typical cycle length for Cagrilintide?
8-20+ weeks depending on response.
How are doses measured in syringe units here?
Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator only when the vial concentration and injection volume are known.